XLV ranks 1st and EKG 19th of 25 funds in the Health Care (Broad) Category.
EKG vs XLV
5.7%by weight
XLV −0.57pt a year
0.65%0.08%
XLV 2094.8×the volume
4.35K9.1M
EKG +7.5pt
+22.7%+15.2%
EKG vs XLV Performance
+27.4%+30.1%
- EKG 0.65%
- XLV 0.08%, better
- EKG $10M
- XLV $48.5B
- EKG +27.4%
- XLV +30.1%, better
- EKG
- XLV 1.38%
- EKG 52
- XLV 64
- EKG 4.35K sh
- XLV 9.1M sh, better
- EKG $23.95
- XLV $184.09
ETF.net Grade
| Pillar | EKG | XLV |
|---|---|---|
| Cost | D27 | A98Higher |
| Mission | A71 | A84Higher |
| Risk | D34 | A78Higher |
| Tradability | D38 | A100Higher |
| Holdings | C46Higher | D39 |
| Durability | F22 | A87Higher |
Rank among Health Care (Broad) funds
Same Category. EKG and XLV are both graded against the same 25 Health Care (Broad) funds, so their Grades compare head to head.
Our read on each fund
EKGD
XLVA
In short
EKG A ticker that spells out the mandate. EKG skips the pharma giants and tracks a Nasdaq index of health technology names: roughly 40 stocks building the digital plumbing of medicine, from diagnostics and devices to health data.
XLV Live since 1998, XLV is the original way to own health care: about 60 S&P 500 names, a 0.08% fee, and one of the busiest tickers in the sector. Big pharma and device makers, not small-cap biotech.
Stated mandate
EKG The Fund seeks to track, before fees and expenses, the price and yield performance of the Nasdaq Lux Health TechTM Index.
XLV The fund seeks to track, before expenses, the price and yield performance of the Health Care Select Sector Index, which represents the health care sector of the S&P 500 Index.
Why people hold it
Worth knowing
EKG vs XLV Holdings
How EKG and XLV differ
5.7%
Shared holdings make up 44.0% of EKG and 5.7% of XLV.
Level by level
- Holdings5.7%
- Sector92.1%
Sector
| Sector | More in EKGMore in XLV | EKG | XLV |
|---|---|---|---|
| Health Care | XLV +8.0 points | 91.3% | 99.3% |
| Technology | EKG +8.0 points | 8.7% | 0.7% |
Country, concentration and asset class
Country
| Country | More in EKGMore in XLV | EKG | XLV |
|---|---|---|---|
| United States | Same weight | 100.0% | 100.0% |
Concentration
- EKG58.6%
- XLV61.0%
- EKG51
- XLV62
Asset class
- EKG
- Equity
- XLV
- Equity
Holdings
- Only in EKG43
- In both8
- Only in XLV54
Only in EKG
43 securities, 55.9% of EKG by weight
- Natera, Inc.9.47%
- Guardant Health, Inc.4.14%
- Qiagen N.v.3.46%
- Globus Medical, Inc. (Class A)3.27%
- Tempus AI, Inc. (Class A)2.80%
- Oscar Health, Inc. (Class A)2.62%
- Hinge Health, Inc. (Class A)2.40%
- Twist Bioscience Corporation2.25%
- GRAIL, Inc.2.00%
- 10X Genomics, Inc. (Class A)1.87%
- Hims & Hers Health, Inc.1.86%
- CareDx, Inc.1.40%
- Heartflow, Inc.1.38%
- Adaptive Biotechnologies Corporation1.32%
- Caris Life Sciences, Inc.1.30%
- Doximity, Inc. (Class A)1.21%
- iRhythm Holdings, Inc.1.12%
- BillionToOne, Inc. (Class A)1.06%
- Waystar Holding Corp.0.89%
- LifeStance Health Group, Inc.0.88%
- Veracyte, Inc.0.86%
- Privia Health Group, Inc.0.66%
- GeneDx Holdings Corp.0.62%
- Establishment Labs Holdings Inc.0.54%
- NeoGenomics, Inc.0.53%
- Inspire Medical Systems, Inc.0.52%
- TransMedics Group, Inc.0.51%
- Progyny, Inc.0.50%
- Butterfly Network, Inc.0.46%
- Teladoc Health, Inc.0.44%
- Schrodinger, Inc.0.42%
- Certara, Inc.0.37%
- Tandem Diabetes Care, Inc.0.35%
- PROCEPT BioRobotics Corporation0.32%
- Alphatec Holdings, Inc.0.32%
- Omada Health, Inc.0.31%
- Cytek Biosciences, Inc.0.25%
- Kestra Medical Technologies, Ltd.0.24%
- QuidelOrtho Corporation0.21%
- Phreesia Inc.0.20%
- Ceribell, Inc.0.20%
- Beta Bionics, Inc.0.18%
- Minimed Group, Inc.0.16%
Only in XLV
54 securities, 94.1% of XLV by weight
- Eli Lilly & Co16.46%
- Johnson & Johnson9.93%
- AbbVie Inc7.70%
- UnitedHealth Group Inc5.52%
- Merck & Co. Inc.5.41%
- Thermo Fisher Scientific Inc3.93%
- Amgen Inc3.73%
- Gilead Sciences Inc3.08%
- Abbott Laboratories2.71%
- Pfizer Inc2.56%
- Danaher Corp2.22%
- Vertex Pharmaceuticals Inc2.05%
- Bristol Myers Squibb Co1.88%
- Medtronic PLC1.78%
- Cvs Health Corp1.73%
- Mckesson Corp1.71%
- Stryker Corp1.63%
- Elevance Health Inc1.37%
- Moderna Inc1.24%
- Regeneron Pharmaceuticals1.20%
- The Cigna Group1.18%
- Hca Healthcare Inc1.05%
- Cencora Inc0.94%
- Boston Scientific Corp0.93%
- Cardinal Health Inc0.87%
- Edwards Lifesciences Corp0.82%
- Becton Dickinson and Co0.81%
- Agilent Technologies Inc0.77%
- Humana Inc0.75%
- Waters Corp0.71%
- Idexx Laboratories Inc0.68%
- Biogen Inc0.55%
- Ge Healthcare Technology0.52%
- Mettler Toledo International0.52%
- Centene Corp0.51%
- Zoetis Inc0.48%
- Labcorp Holdings Inc0.45%
- West Pharmaceutical Services0.44%
- Quest Diagnostics Inc0.42%
- Steris PLC0.34%
- Viatris Inc0.33%
- Incyte Corp0.30%
- Zimmer Biomet Holdings Inc0.28%
- Revvity Inc0.28%
- Charles River Laboratories0.27%
- Baxter International Inc0.18%
- Solventum Corp0.18%
- Cooper Cos Inc/The0.18%
- Bio Techne Corp0.17%
- Universal Health Services B0.14%
Weight gaps
All 8 Holdings in both funds, largest gap first.
| Holding | More in EKGMore in XLV | EKG | XLV |
|---|---|---|---|
| Veeva Systems Inc. (Class A) | EKG +7.36 points | 8.05% | 0.69% |
| IQVIA Holdings Inc. | EKG +6.85 points | 7.53% | 0.68% |
| DexCom, Inc. | EKG +6.20 points | 6.65% | 0.45% |
| Intuitive Surgical, Inc. | EKG +6.07 points | 8.44% | 2.37% |
| Illumina, Inc. | EKG +3.40 points | 4.06% | 0.66% |
| ResMed Inc. | EKG +2.97 points | 3.52% | 0.55% |
| Insulet Corporation | EKG +2.88 points | 3.04% | 0.16% |
| Align Technology, Inc. | EKG +2.60 points | 2.75% | 0.15% |
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
EKG vs XLV Cost
Overpaying EKG vs XLV
$11,028
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
EKG 0.65%
$12,717
XLV 0.08%
$1,689
Cost over time
Year by year
| Year | EKG | XLV | Overpaying |
|---|---|---|---|
| 10 | $1,163 | $147 | $1,016 |
| 20 | $4,440 | $575 | $3,865 |
| 30 | $12,717 | $1,689 | $11,028 |
- 0.65%EKG
- 0.08%XLV, cheaper
- Middle half of Health Care (Broad) funds
- Median 0.50%
XLV cheapest of 25 funds
EKG 18th cheapest of 25 funds
EKG vs XLV Dividends
- EKG
- XLV 1.38%
- EKG None
- XLV $2.55
- EKG
- XLV $0.64
- EKG
- XLV Sep 21, 2026
- EKG
- XLV Sep 23, 2026
- EKG
- XLV Quarterly
Distribution history
EKG vs XLV Risk
Fall from peak · 5 years
Risk facts
- Volatility
- EKG 22.1%XLV 14.8%, better
- Return per unit of risk
- EKG 0.92, betterXLV 0.78
- Worst fall
- EKG −43.8%XLV −17.1%
- Market sensitivity
- EKG 1.43XLV 0.56
EKG and XLV in the news
Popular comparisons
- 0.65% · 0.08%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.08% · 0.08%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.65% · 0.09%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.08% · 0.09%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.65% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.08% · 0.35%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.





